Yifan Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 938.53 million compared to CNY 905.92 million a year ago. Revenue was CNY 938.53 million compared to CNY 905.92 million a year ago.

Net income was CNY 64.77 million compared to CNY 121.27 million a year ago. Basic earnings per share from continuing operations was CNY 0.05 compared to CNY 0.1 a year ago. Diluted earnings per share from continuing operations was CNY 0.05 compared to CNY 0.1 a year ago.